Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 48433-032

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 48433-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Unit Carton (Unit Carton)

FDA Label Image

Diltiazem Hydrochloride Structural Formula (Image 01)

Not available.*

FDA Label Image

Diltiazem HCl 60 mg Extended-release Capsules, Usp Unit Carton Label (Image 02)

FDA Label Image

Diltiazem HCl 90 mg Extended-release Capsules, Usp Unit Carton Label (Image 03)

FDA Label Image

Diltiazem HCl 120 mg Extended-release Capsules, Usp Unit Carton Label (Image 05)

This is a description of Diltiazem HCI Extended-Release Capsules, USP with the National Drug Code 48433-032-20. The capsules are formulated for controlled release and each capsule contains 120 mg of Diltiazem HCI. It is prescribed as a medication for conditions that can be treated with Diltiazem HCI. Please consult a healthcare professional for proper diagnosis and treatment.*

FDA Label Image

Unit Carton (Image 06)

This is a description for a package of resistant containers suitable for institutional use. The package includes child-resistant lids and provides a light resistance. The product is distributed by Safecor Health LLC in Rockford, IL, USA. For inquiries, contact 1-800-447-1006 or visit SafecorHealth.com.*

FDA Label Image

Unit Carton (Image 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.